Please login to the form below

Not currently logged in
Email:
Password:

Pfizer's Mark Brincat joins Exco InTouch to lead its mHealth strategy

Brincat was the pharma company's former European healthcare informatics director

Mark Brincat has been appointed product development director at Exco InTouch, a Nottingham, UK-based firm that provides interactive mobile patient communication tools for clinical trials.

He joins the company from Pfizer where he where he spent the last thirteen years managing the delivery of emerging and innovative business technology at Pfizer.

Most recently Brincat served as the pharma company's European healthcare informatics director, working across clinical trials, drug compliance, disease management and 'wellness'.

He also managed the first ever remote patient clinical trial, working with Exco and its mobile diary technology.

In his new role at Exco InTouch Brincat will lead mHealth and mobile product strategy with a particular focus on developing targeted tools for specific therapy areas.

He said: "We all know that healthcare is at a crossroads, so there is no better time to be working with pharmaceutical and healthcare providers to deliver effective and innovative new mHealth solutions directly to patients.”

30th January 2012

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics